Records containing: Ovary Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study results posted · 2026-07-02Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase II Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine-gynx and Olaparib in Recurrent Platinum Sensitive Ovarian, Peritoneal, and Fallopian Tube Cancer
-
CLINICAL_TRIALS study record update · 2026-03-24The Impact of Alternate Day Fasting After Surgery for Patients Undergoing chemoTherapy (FAST Study)
-
CLINICAL_TRIALS study record update · 2026-03-23A Pilot and Mixed-Methods Study of GYNecologic Cancer-Related COGnitive Impairment
-
CLINICAL_TRIALS study record update · 2026-03-09Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-04A Randomized Trial of Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
-
CLINICAL_TRIALS study record update · 2026-02-20A Seamless Phase 1/2 Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Autologous Logic-gated Tmod™ CAR T Products, in Heterozygous HLA-A*02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
-
CLINICAL_TRIALS study record update · 2025-11-12Multimedia Aid for Genetic Testing in Gynecologic Oncology
-
CLINICAL_TRIALS study record update · 2025-11-06Phase 1/2 Safety and Efficacy Study of NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-10-27A Phase 2 Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-10-08No-Stoma Policy in Advanced Ovarian Cancer Surgery, Feasibility and Outcomes
-
CLINICAL_TRIALS study record update · 2025-10-02A Phase I/II Dose Escalation, Safety and Efficacy Study of Anti-NY-ESO-1 T Cell Receptor (TCR)-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
-
CLINICAL_TRIALS study record update · 2025-09-23A Pan-European Non-interventional, Retrospective Observational Cohort Study of Patients With BRCA Mutated Advanced (FIGO Stage III-IV) Ovarian Cancer Treated With Olaparib Tablets in the First-line Maintenance Setting
-
CLINICAL_TRIALS study record update · 2025-09-22A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers)
-
CLINICAL_TRIALS study record update · 2025-08-20A Phase 1 Open-Label, Safety, Pharmacokinetic and Preliminary Efficacy Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody-Drug Conjugate (ADC), in Patients With Advanced Epithelial Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) and Endometrial Cancers
-
CLINICAL_TRIALS study record update · 2025-07-31An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-07-20First-in-Human, Dose Finding, Open Label Phase 1A-1B Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2025-07-16Overall Survival Following Interval and Delayed Cytoreduction Surgery in Advanced Stage Ovarian Cancer: a Pragmatic Phase III Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2025-07-08Disitamab Vedotin (RC48) in Combination With AK104 (PD-1/CTLA-4 Bispecific) and Bevacizumab for the Treatment of Recurrent and Persistent Clear Cell Ovarian Cancer
-
CLINICAL_TRIALS study record update · 2025-06-19A PHASE 2 EFFICACY TRIAL OF INTENSIVE LOCOREGIONAL CHEMOIMMUNOTHERAPY FOR ADVANCED STAGE OVARIAN CANCER AND TUMOR-SPECIFIC INTRANODAL AUTOLOGOUS ALPHA-DC1 VACCINES
-
CLINICAL_TRIALS study record update · 2025-06-12Adapting MultiPLe Behavior Interventions That eFfectively Improve (AMPLIFI) Cancer Survivor Health
-
CLINICAL_TRIALS study record update · 2025-04-29Patient-Tailored Physical Activity Intervention Among Older Women With Gynecologic Cancers Undergoing Chemotherapy (Fit4Treatment)
-
CLINICAL_TRIALS study record update · 2025-03-12CT Detected Tumour Infiltration Patterns of the Mesentery in High Grade Ovarian Carcinoma (HGSOC) Patients, Their Role in Treatment Planning and Outcome Prediction and How Machine Learning Can be Applied to Identify Them.
-
CLINICAL_TRIALS study record update · 2025-02-03Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)
-
CLINICAL_TRIALS study record update · 2025-01-29Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study